跳转至内容
Merck
CN

540080

(S)-(+)-环氧氯丙烷

98%

别名:

(S)-(+)-2-(氯甲基)环氧乙烷

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C3H5ClO
化学文摘社编号:
分子量:
92.52
UNSPSC Code:
12352005
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1420784
Assay:
98%
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


vapor density

3.2 (vs air)

Quality Level

vapor pressure

12.5 mmHg ( 20 °C)

assay

98%

optical activity

[α]20/D +35°, c = 1 in methanol

optical purity

ee: 97% (GLC)

autoignition temp.

1421 °F

expl. lim.

21 %

refractive index

n20/D 1.438 (lit.)

bp

92-93 °C/360 mmHg (lit.)

density

1.183 g/mL at 25 °C (lit.)

functional group

chloro, ether

SMILES string

ClC[C@@H]1CO1

InChI

1S/C3H5ClO/c4-1-3-2-5-3/h3H,1-2H2/t3-/m1/s1

InChI key

BRLQWZUYTZBJKN-GSVOUGTGSA-N

Application

用于对映选择性合成羟基异噁唑烷和 (+)-顺式-sylvaticin(一种有潜力的抗肿瘤剂)的手性结构单元。
作为潜在的代谢调节剂,用以合成脂肪酸氧化抑制剂。
用于 Macquarimicins 的全合成和大环内酯 RK-397 的全合成。

Legal Information

经Sterling Pharma Solutions Limited许可,使用Jacobsen HKR技术制造。


signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - Eye Dam. 1 - Flam. Liq. 3 - Skin Corr. 1B - Skin Sens. 1

存储类别

3 - Flammable liquids

flash_point_f

89.6 °F - closed cup

flash_point_c

32 °C - closed cup

ppe

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

法规信息

危险化学品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Ryosuke Munakata et al.
Journal of the American Chemical Society, 125(48), 14722-14723 (2003-12-04)
The first total synthesis of (+)-macquarimicin A (1), a novel inhibitor of neutral sphingomyelinase (N-SMase) with antiinflammatory activity, has been accomplished. The present work determined the absolute configuration of (+)-1 and revised the C(2)-C(3) geometry to be Z. The synthesis
Tetrahedron Letters, 47, 7635-7635 (2006)
Elfatih Elzein et al.
Bioorganic & medicinal chemistry letters, 14(4), 973-977 (2004-03-12)
We describe the synthesis of novel inhibitors of fatty acid oxidation as potential metabolic modulators for the treatment of stable angina. Replacement of the 2H-benzo[d]1,3-dioxolene ring system in our initial lead 3 with different benzthiazoles, benzoxazoles and introducing small alkyl



全球贸易项目编号

货号GTIN
540080-25G04061837641329
540080-5G04061837641336